Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 05 - 06 crawled time : 01:00 save search
2021 Letter to Shareholders
Published: 2021-05-06 (Crawled : 01:00) - xoma.com
XOMA | $25.11 -3.76% -3.9% 8.2K
|
Health Technology
|
| O: -0.73%
H: 0.44%
C: -8.06%
Extra Space Announces Pricing of $450 Million of 2.550% Senior Notes due 2031
Published: 2021-05-06 (Crawled : 01:00) - prnewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: 0.5%
H: 2.33%
C: 2.24%
EXR | $134.64 1.02% -0.48% 1.1M
|
Finance
|
| O: 0.23%
H: 0.34%
C: -0.43%
space spac
E-Learning Market in the US will Accelerate at a CAGR of over 17% through 2021-2025|Evolved learning and education landscape to upheave Growth|Technavio
Published: 2021-05-06 (Crawled : 01:00) - prnewswire.com
COUR S | $11.92 -1.65% 0.0% 1.6M
|
Educational Services
|
| O: 0.24%
H: 0.8%
C: -7.43%
RELX | $41.43 -1.96% 0.0% 1.4M
|
Commercial Services
|
| O: 0.0%
H: 0.53%
C: 0.49%
ADBE A | $477.11 0.89% 0.88% 2M
|
Technology Services
|
| O: -0.21%
H: 0.0%
C: -0.42%
education growth
Everest Medicines Receives Orphan Drug Designation from the Ministry of Food and Drug Safety in South Korea for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer
Published: 2021-05-06 (Crawled : 01:00) - prnewswire.com
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.71%
H: 0.97%
C: 0.76%
food cancer drug breast cancer designation
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
DMAC | $2.5 3.31% 3.2% 7.4K
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: -2.07%
financial results results
Stealth BioTherapeutics Showcases Data for Elamipretide in Dry Age-Related Macular Degeneration at the 2021 ARVO Annual Meeting
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
MITO | $0.32 0.25%
|
Health Technology
|
| O: 0.0%
H: 1.65%
C: -0.83%
iot macular elamipretide
ADC Therapeutics’ ZYNLONTA™ (loncastuximab tesirine-lpyl) Added to National Comprehensive Cancer Network® Clinical Practice Guidelines in Oncology for B-cell Lymphomas
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -0.67%
H: 2.95%
C: -1.79%
cancer t-cell
Equinox Gold Announces Results From Annual General Meeting
Published: 2021-05-06 (Crawled : 01:00) - prnewswire.com
EQX | $5.24 -8.39% -0.19% 20M
|
Non-Energy Minerals
|
| O: 1.23%
H: 5.37%
C: 3.29%
results
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Combined With Trastuzumab and Chemotherapy as First-line Treatment in Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
MRK | $127.0 0.1% -1.21% 7.1M
|
Health Technology
|
| O: 0.14%
H: 2.14%
C: 2.1%
treatment fda positive therapy fda approval her2+ keytruda her2- her2
New England Journal of Medicine Publishes Phase 2b Clinical Trial Results Demonstrating Efficacy of Novavax COVID-19 Vaccine Against the B.1.351 Variant
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
NVAX | $4.15 -0.96% -0.96% 2.4M
|
Health Technology
|
| O: 3.47%
H: 4.31%
C: -8.13%
covid phase 2 results vaccine phase 2b trial trial results
MediciNova Receives a Notice of Intention to Grant for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Europe
Published: 2021-05-06 (Crawled : 01:00) - globenewswire.com
MNOV | $1.33 -3.73% 8K
|
Health Technology
|
| O: 2.35%
H: 0.23%
C: -8.05%
treatment europe sclerosis patent als mn-166 riluzole
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.